266 related articles for article (PubMed ID: 32036157)
1. Utility of the platelet function analyser (PFA-100/200) for exclusion or detection of von Willebrand disease: A study 22 years in the making.
Favaloro EJ
Thromb Res; 2020 Apr; 188():17-24. PubMed ID: 32036157
[TBL] [Abstract][Full Text] [Related]
2. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
Favaloro EJ; Facey D; Henniker A
Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
4. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
[TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies.
Favaloro EJ; Kershaw G; Bukuya M; Hertzberg M; Koutts J
Haemophilia; 2001 Mar; 7(2):180-9. PubMed ID: 11260278
[TBL] [Abstract][Full Text] [Related]
6. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
[TBL] [Abstract][Full Text] [Related]
7. Laboratory characterization of obligate carriers of type 3 von Willebrand disease with a potential role for Platelet Function Analyzer (PFA-200).
Geevar T; Dave RG; Mathews NS; Kumar S; Mammen JJ; Vijayan R; Aboobacker FN; Abraham A; Srivastava A; Nair SC
Int J Lab Hematol; 2022 Jun; 44(3):603-609. PubMed ID: 34986515
[TBL] [Abstract][Full Text] [Related]
8. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
Favaloro EJ
Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function.
Nummi V; Lassila R; Joutsi-Korhonen L; Armstrong E; Szanto T
Int J Lab Hematol; 2018 Jun; 40(3):304-311. PubMed ID: 29427305
[TBL] [Abstract][Full Text] [Related]
10. Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer.
Pekrul I; Kragh T; Turecek PL; Novack AR; Ott HW; Spannagl M
Platelets; 2019; 30(2):264-270. PubMed ID: 29319374
[TBL] [Abstract][Full Text] [Related]
11. The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome - an observational study.
Büchsel M; Geisen U; Beckenkamp C; Wengenmayer T; Zieger B; Westermann D; Siegel PM
Thromb J; 2023 Jan; 21(1):4. PubMed ID: 36627675
[TBL] [Abstract][Full Text] [Related]
12. The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group.
Nitu-Whalley IC; Lee CA; Brown SA; Riddell A; Hermans C
Haemophilia; 2003 May; 9(3):298-302. PubMed ID: 12694521
[TBL] [Abstract][Full Text] [Related]
13. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review.
Favaloro EJ
Semin Thromb Hemost; 2006 Jul; 32(5):537-45. PubMed ID: 16862528
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease.
Cattaneo M; Federici AB; Lecchi A; Agati B; Lombardi R; Stabile F; Bucciarelli P
Thromb Haemost; 1999 Jul; 82(1):35-9. PubMed ID: 10456451
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
Favaloro EJ; Mohammed S
Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192
[TBL] [Abstract][Full Text] [Related]
16. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of laboratory methods to improve characterization of dogs with von Willebrand disease.
Burgess HJ; Woods JP; Abrams-Ogg AC; Wood RD
Can J Vet Res; 2009 Oct; 73(4):252-9. PubMed ID: 20046626
[TBL] [Abstract][Full Text] [Related]
18. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
Shihong I; Morris D; Konkle BA
Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
[TBL] [Abstract][Full Text] [Related]
19. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the DDAVP infusion test with PFA-100 and vWF activity assays to distinguish vWD types in children.
Akin M; Karapinar DY; Balkan C; Ay Y; Kavakli K
Clin Appl Thromb Hemost; 2011 Oct; 17(5):441-8. PubMed ID: 20460340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]